共 51 条
[1]
Li D(2019)Juvenile dermatomyositis—clinical phenotypes Curr Rheumatol Rep 21 74-2816
[2]
Tansley SL(2016)Muscle biopsy findings in combination with myositis-specific autoantibodies aid prediction of outcomes in juvenile dermatomyositis: prediction of outcomes in juvenile myositis Arthritis Rheumatol 68 2806-19
[3]
Deakin CT(2017)A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy Clin Rev Allergy Immunol 52 1-535
[4]
Yasin SA(1997)Classification criteria for the idiopathic inflammatory myopathies Curr Opin Rheumatol 9 527-64
[5]
Simou S(2017)Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort J Autoimmun 84 55-38
[6]
Arnold KA(2016)The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes J Intern Med 280 24-27
[7]
Tansley SL(2018)Advances in juvenile dermatomyositis: myositis specific antibodies aid in understanding disease heterogeneity J Pediatr 195 16-2208
[8]
Betteridge ZE(2014)Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset Rheumatology (Oxford) 53 2204-677
[9]
McHugh NJ(2011)Anti-melanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis J Pediatr 158 675-929
[10]
Varsani H(2008)Autoantibody to signal recognition particle in African American girls with juvenile polymyositis J Rheumatol 35 927-undefined